Genetic Technologies Ltd (GENE)
2.40
+0.09
(+3.90%)
USD |
NASDAQ |
Apr 23, 16:00
2.40
0.00 (0.00%)
After-Hours: 17:24
Genetic Technologies Total Liabilities (Quarterly): 1.799M for June 30, 2020
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.49M |
| June 30, 2023 | 2.445M |
| December 31, 2022 | 3.174M |
| June 30, 2022 | 3.007M |
| December 31, 2021 | 2.241M |
| June 30, 2021 | 1.081M |
| December 31, 2020 | 1.048M |
| June 30, 2020 | 1.127M |
| December 31, 2019 | 1.037M |
| June 30, 2019 | 1.046M |
| December 31, 2018 | 0.7728M |
| December 31, 2018 | 0.7728M |
| June 30, 2018 | 1.068M |
| December 31, 2017 | 0.9463M |
| June 30, 2017 | 1.175M |
| December 31, 2016 | 1.278M |
| June 30, 2016 | 1.050M |
| December 31, 2015 | 0.899M |
| June 30, 2015 | 1.350M |
| December 31, 2014 | 2.576M |
| Date | Value |
|---|---|
| June 30, 2014 | 4.615M |
| December 31, 2013 | 7.063M |
| June 30, 2013 | 2.377M |
| December 31, 2012 | 1.979M |
| June 30, 2012 | 2.046M |
| December 31, 2011 | 1.626M |
| June 30, 2011 | 2.253M |
| December 31, 2010 | 2.435M |
| June 30, 2010 | 2.154M |
| December 31, 2009 | 2.536M |
| June 30, 2009 | 3.115M |
| December 31, 2008 | 2.539M |
| June 30, 2008 | 3.169M |
| December 31, 2007 | 2.372M |
| June 30, 2007 | 2.836M |
| December 31, 2006 | 3.068M |
| June 30, 2006 | 3.099M |
| December 31, 2005 | 2.724M |
| June 30, 2005 | 4.960M |
| December 31, 2004 | 3.678M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.037M
Minimum
Dec 2019
3.174M
Maximum
Dec 2022
1.870M
Average
1.684M
Median
Total Liabilities (Quarterly) Benchmarks
| Alterity Therapeutics Ltd | 2.345M |
| Kazia Therapeutics Ltd | 10.61M |
| Immutep Ltd | 9.137M |
| Opthea Ltd | 213.41M |
| Mesoblast Ltd | 167.58M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.74M |
| Shareholders Equity (Quarterly) | 8.943M |